J Martin Herold

Title: J Martin Herold: Innovator in Kinase Inhibitors

Introduction

J Martin Herold is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. With a total of three patents to his name, Herold's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Herold's latest patents include innovative compounds aimed at inhibiting tyrosine kinase 2 mediated signaling. The first patent discloses compounds of Formula (I) and their pharmaceutically acceptable salts, which are designed for pharmaceutical compositions and methods of preparation and use. The second patent focuses on heterocyclic kinase inhibitors, providing compounds of Formula (I) that include pro-drugs, biologically active metabolites, and stereoisomers. These compounds are particularly useful for treating immunological and oncological conditions.

Career Highlights

J Martin Herold is currently associated with AbbVie Inc., a leading biopharmaceutical company. His work at AbbVie has allowed him to further his research and development efforts in the field of kinase inhibitors, contributing to advancements in medical treatments.

Collaborations

Herold has collaborated with notable colleagues, including Michael M Friedman and Kristine E Frank. These collaborations have likely enhanced the scope and impact of his research.

Conclusion

J Martin Herold's innovative work in the field of kinase inhibitors showcases his dedication to advancing pharmaceutical science. His contributions have the potential to lead to significant improvements in the treatment of various diseases.